Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
about
Platelet count, spleen length, and platelet count/spleen length ratio for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisHuman platelets and their capacity of binding viruses: meaning and challenges?Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus InfectionThe pathogenesis of immune thrombocytopaenic purpuraThrombocytopenia and infections.Platelet count increase following phlebotomy in iron overloaded patients with liver cirrhosis.Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1.Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia.Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients.Autoimmune thrombocytopenia related to chronic hepatitis C virus infection.Pathobiology of secondary immune thrombocytopenia.The ITP syndrome: pathogenic and clinical diversity.Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy.Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection.Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag.Interferon-alpha induced severe thrombocytopenia: a case report and review of the literature.Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitisPathobiology and treatment of hepatitis virus-related thrombocytopenia.Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy.Romiplostim in the management of thrombocytopenia in a patient with autoimmune hepatitis.Immunological HCV-associated thrombocytopenia: short reviewImmunological alterations in hepatitis C virus infection.The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case reportThe role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Management of thrombocytopenia in advanced liver diseaseTherapeutic efficacy of splenectomy is attenuated by necroinflammation of the liver in patients with liver cirrhosis.Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India.Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literaturePlatelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial.Management of Hepatitis C Antiviral Therapy Adverse Effects.Platelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: The special Egyptian situation: Noninvasive prediction of esophageal varices.The human microbiome in hematopoiesis and hematologic disorders.Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infectionThe management of side-effects during therapy for hepatitis C.UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011.Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.Immune thrombocytopenic purpura might be an early hematologic manifestation of undiagnosed human immunodeficiency virus infection.Role of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients.Higher hepatitis C [correction of hepatis C ] virus concentration in platelets than in plasma in a patient with ITP.
P2860
Q24234737-8CA3DA6A-7275-4BD0-870C-8F1F0481C2C5Q26997803-D826EA91-58EB-472A-A37C-6D32171FE4C8Q27490427-5D264786-2898-40FA-856A-83EE0444840FQ28236898-713921D0-5285-452A-BD87-7F9157142BD3Q30240119-4ABB71DD-A46C-40A0-A6D8-A9A205A569F4Q33349456-74EE7E8E-1401-4BA1-8F04-ED304ECCBAC5Q33362537-2D21EDD7-06CA-42F0-B0A1-4D223BBBE477Q33368703-C5EED28F-239B-447D-B1B9-E46893A176BBQ33370831-CD3D684B-1445-4255-9A20-EFAB98162195Q33376165-71CC6718-5F9E-46C8-8CE5-08A7F92F8A77Q33382854-8AB73CB7-244F-4A3F-AEEF-AFEEC76318DEQ33383468-BB578274-7EA5-4336-9981-F5635AF17D12Q33384235-AB17CA60-8544-4B51-97C0-49216776AC70Q33386133-D9DAFAE0-853C-4B23-82A1-84FAAD881AC1Q33386712-97062C89-980F-45AF-84FF-C5342EDE8DE9Q33387808-F15D0408-7244-4094-A17B-8999B1BED8C1Q33388664-644533D6-095F-4428-933F-21709B0CD9CAQ33394544-2C0E1134-5401-44E2-ABC9-9967DFADCAC8Q33394547-C64515EE-61B5-44DB-902C-FB3C622B359AQ33395500-4BC78C44-B676-4B70-BB75-092CADFC128BQ33402513-15E65824-AB0A-4662-B194-A4D01CA9E965Q33402517-AE2F1038-DF80-408C-A41D-A3800B8AAAF7Q33412382-A5C96266-1076-43AD-978D-637B0F45DC21Q33412844-7785105E-2CB8-47C5-AA72-B37293CF4842Q33414386-00DFA36E-8BF7-4DC4-9BB8-7CF545FB7FF0Q33417667-36CECC5C-8E35-4C85-BAD2-DB9AF6F294FDQ33418387-4DEDD9B8-D187-4B3E-BB68-B90E046CBE1AQ33421032-B0D34A81-6093-4455-B635-FF468F77832FQ33424123-316EC7ED-F50F-4F2A-83CB-B086AF02A82DQ33441776-93BB325D-C4FA-4D71-B1DF-60F9EEC3C9C9Q34538771-20BEE66E-F18E-4C49-8B28-14A8B6E845E0Q35507769-75A2421C-C146-4AED-9CBA-FD94DCB5DC6FQ35642328-B8B9D08B-3BB9-4C66-8EE5-FB25EF0CC1B2Q35731058-2939F7EE-0267-4422-BAEC-AA986E723867Q35936934-936F53B6-E6A4-4008-81D8-3FDB69C0E13AQ37887065-8C80C6DE-9E20-44FE-B2DE-0094E458FD32Q38690661-7C1C6489-FCEA-4611-AB23-2660737F0011Q39452896-1FB0450D-7C6E-4119-8E13-A218CBCE31D8Q41860936-8BC20EE6-AC4F-434B-8108-CE3D905D2395Q43041507-B176C738-98C2-4766-9C26-A1CDDF5D88ED
P2860
Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
@ast
Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
@en
type
label
Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
@ast
Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
@en
prefLabel
Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
@ast
Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
@en
P2093
P2860
P1476
Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
@en
P2093
Andrea Duchini
Eric Viernes
John McHutchison
Lisa M Nyberg
Paul J Pockros
Robert McMillan
P2860
P304
P356
10.1111/J.1572-0241.2002.05845.X
P407
P577
2002-08-01T00:00:00Z